We are live on ! Find out more
CC

Cannell Capital Portfolio holdings

AUM $163M
1-Year Est. Return 40.62%
This Fund
S&P 500
This Quarter Est. Return
-6.85%
1 Year Est. Return
+40.62%
3 Year Est. Return
+130.22%
5 Year Est. Return
+162.5%
10 Year Est. Return
+2,439.17%
AUM
$437M
AUM Growth
-$61.3M
Cap. Flow
-$10.7M
Cap. Flow %
-2.45%
Top 10 Hldgs %
49.49%
Holding
96
New
6
Increased
45
Reduced
18
Closed
8

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 29.97%
2 Energy 18.49%
3 Industrials 13.98%
4 Communication Services 13.09%
5 Financials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGICA icon
51
Donegal Group Class A
DGICA
$731M
$590K 0.14%
+43,722
New +$659K
PMD
52
DELISTED
Psychemedics Corporation
PMD
$575K 0.13%
89,211
PPIH
53
Perma-Pipe International
PPIH
$196M
$535K 0.12%
56,625
+3,874
+7% +$35.8K
WINA icon
54
Winmark
WINA
$1.2B
$476K 0.11%
2,200
POL.WS
55
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$438K 0.1%
3,501,673
-1,628,359
-32% -$386K
EMKR
56
DELISTED
Emcore Corp
EMKR
$403K 0.09%
24,120
-288,619
-92% -$7.71M
SSKN
57
DELISTED
Strata Skin Sciences
SSKN
$365K 0.08%
41,938
HIL
58
DELISTED
Hill International, Inc. Common Stock
HIL
$304K 0.07%
91,589
-47,000
-34% -$116K
DFIN icon
59
Donnelley Financial Solutions
DFIN
$1.16B
$259K 0.06%
7,000
-4,200
-38% -$157K
CVR icon
60
Chicago Rivet & Machine Co
CVR
$10M
$255K 0.06%
9,886
+5,217
+112% +$143K
GTX icon
61
Garrett Motion
GTX
$5.81B
$246K 0.06%
43,500
BCIC
62
BCP Investment Corp
BCIC
$89.1M
$87K 0.02%
4,154
DMLP icon
63
Dorchester Minerals
DMLP
$1.33B
$85K 0.02%
3,399
LVTX
64
DELISTED
LAVA Therapeutics
LVTX
$82K 0.02%
17,955
+13,897
+342% +$38.3K
VIGL
65
DELISTED
Vigil Neuroscience
VIGL
$73K 0.02%
8,044
+4,408
+121% +$32.3K
OMGA
66
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$51K 0.01%
9,433
+6,695
+245% +$33.9K
SPRY icon
67
ARS Pharmaceuticals
SPRY
$509M
$50K 0.01%
9,402
+6,833
+266% +$33.7K
XLO icon
68
Xilio Therapeutics
XLO
$59.9M
$50K 0.01%
1,216
+891
+274% +$34.6K
GRCL
69
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$46K 0.01%
14,299
+12,110
+553% +$39.4K
TCRX icon
70
TScan Therapeutics
TCRX
$48.6M
$45K 0.01%
14,666
+11,012
+301% +$36.1K
LENZ
71
LENZ Therapeutics
LENZ
$166M
$45K 0.01%
2,044
+1,479
+262% +$35.2K
KEQU icon
72
Kewaunee Scientific
KEQU
$102M
$44K 0.01%
2,482
OVID icon
73
Ovid Therapeutics
OVID
$414M
$42K 0.01%
22,620
+16,671
+280% +$34.9K
GBIO
74
DELISTED
Generation Bio
GBIO
$41K 0.01%
777
+602
+344% +$37.7K
GANX icon
75
Gain Therapeutics
GANX
$71.7M
$40K 0.01%
12,371
+9,620
+350% +$36.1K

Similar funds

Cannell Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Cannell Capital held 96 positions worth $437M, down 12% from $498M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Cannell Capital's Q3 2022 filing shows 6 new, 45 increased, 18 reduced and 8 closed positions. Its largest new stake was Latham Group: 963,173 shares worth $3.46M. The largest sale was Heritage-Crystal Clean, Inc., an estimated $16.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 30% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

  • Cannell Capital's largest Q3 2022 buy was Latham Group: 963,173 shares worth $3.46M.
  • Cannell Capital added most to Lincoln Educational Services in Q3 2022, an estimated $8.18M increase.
  • Cannell Capital's biggest Q3 2022 reduction was Heritage-Crystal Clean, Inc., cutting an estimated $16.1M.
  • Cannell Capital fully exited Quotient Technology Inc in Q3 2022, selling an estimated $7.57M.
  • Cannell Capital's ten largest holdings make up 49% of its $437M portfolio in Q3 2022.
  • Cannell Capital opened 6 new positions and closed 8 in Q3 2022.
  • Cannell Capital's portfolio value fell 12% quarter-over-quarter to $437M.

Based on Cannell Capital's 13F filing for Q3 2022, filed 14 Nov 2022.